| Code | Description | Claims | Beneficiaries | Total Paid |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
34,412 |
29,975 |
$3.30M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
30,105 |
27,650 |
$2.90M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
17,080 |
14,645 |
$1.64M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
5,184 |
4,833 |
$456K |
| 36415 |
Collection of venous blood by venipuncture |
29,476 |
20,849 |
$419K |
| 80053 |
Comprehensive metabolic panel |
36,486 |
29,213 |
$305K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
3,397 |
3,062 |
$214K |
| 70450 |
Computed tomography, head or brain; without contrast material |
5,825 |
4,883 |
$194K |
| 87400 |
|
4,223 |
3,829 |
$166K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
2,071 |
1,858 |
$151K |
| 87430 |
|
2,754 |
2,649 |
$123K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
2,418 |
804 |
$122K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
3,766 |
3,172 |
$113K |
| 87486 |
|
8,765 |
8,340 |
$110K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
9,540 |
9,072 |
$102K |
| 99218 |
|
4,712 |
2,471 |
$84K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
920 |
851 |
$84K |
| 87088 |
|
8,601 |
7,409 |
$83K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
3,610 |
2,810 |
$82K |
| 81001 |
|
18,712 |
16,411 |
$80K |
| 71045 |
Radiologic examination, chest; single view |
15,153 |
12,973 |
$68K |
| 84484 |
|
10,062 |
7,355 |
$65K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
5,778 |
4,575 |
$60K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
4,128 |
2,858 |
$57K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
1,372 |
1,242 |
$47K |
| 71046 |
Radiologic examination, chest; 2 views |
2,820 |
2,654 |
$44K |
| 86850 |
|
2,192 |
1,800 |
$43K |
| A9270 |
Non-covered item or service |
45,544 |
22,252 |
$43K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
379 |
334 |
$39K |
| 86900 |
|
3,688 |
3,176 |
$38K |
| 73610 |
|
1,052 |
902 |
$35K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
1,662 |
1,469 |
$35K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
258 |
230 |
$31K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
26,369 |
20,925 |
$30K |
| 87210 |
|
3,553 |
3,333 |
$30K |
| 81003 |
|
4,359 |
3,916 |
$30K |
| 73562 |
|
1,070 |
888 |
$29K |
| 82947 |
|
1,818 |
1,102 |
$28K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
13,477 |
10,916 |
$27K |
| 76801 |
|
2,149 |
1,764 |
$25K |
| 73630 |
|
1,008 |
912 |
$24K |
| 84112 |
|
400 |
360 |
$23K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
773 |
694 |
$23K |
| 73030 |
|
796 |
658 |
$22K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
2,143 |
1,782 |
$22K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
3,516 |
2,845 |
$21K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
698 |
646 |
$21K |
| 73130 |
|
610 |
539 |
$20K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
1,113 |
1,037 |
$20K |
| 84702 |
|
3,038 |
2,332 |
$19K |
| 85027 |
|
12,480 |
10,457 |
$17K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
10,277 |
8,435 |
$17K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
598 |
557 |
$17K |
| 93975 |
|
1,145 |
1,088 |
$17K |
| 87040 |
|
4,683 |
3,429 |
$15K |
| J1644 |
Injection, heparin sodium, per 1000 units |
2,260 |
1,134 |
$15K |
| 85610 |
|
7,306 |
5,380 |
$15K |
| 73110 |
|
519 |
435 |
$14K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
1,955 |
1,577 |
$14K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
5,596 |
4,424 |
$14K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
1,548 |
885 |
$14K |
| 85730 |
|
5,738 |
4,742 |
$13K |
| J2704 |
Injection, propofol, 10 mg |
2,254 |
1,840 |
$13K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
612 |
555 |
$13K |
| 94664 |
|
3,857 |
2,789 |
$13K |
| 94760 |
|
4,168 |
3,027 |
$13K |
| 87420 |
|
1,566 |
1,500 |
$11K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
3,574 |
3,332 |
$11K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
3,915 |
2,884 |
$11K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
3,734 |
3,288 |
$10K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
3,617 |
3,377 |
$10K |
| 87071 |
|
1,186 |
986 |
$10K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
2,337 |
1,961 |
$10K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
928 |
881 |
$9K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
6,523 |
4,616 |
$9K |
| 93017 |
|
270 |
239 |
$9K |
| 83605 |
|
4,310 |
3,645 |
$9K |
| 80061 |
Lipid panel |
2,471 |
2,095 |
$9K |
| 81025 |
|
2,549 |
2,380 |
$9K |
| 93041 |
|
10,115 |
8,620 |
$8K |
| G0378 |
Hospital observation service, per hour |
1,052 |
809 |
$8K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
5,465 |
4,889 |
$8K |
| 73502 |
|
540 |
429 |
$8K |
| 72100 |
|
263 |
215 |
$8K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
1,220 |
1,136 |
$8K |
| 83880 |
|
2,615 |
2,133 |
$7K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
1,836 |
1,516 |
$7K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
1,591 |
1,314 |
$7K |
| 76830 |
Ultrasound, transvaginal |
703 |
663 |
$6K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
1,441 |
1,066 |
$6K |
| 93971 |
|
752 |
664 |
$6K |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
250 |
202 |
$6K |
| 96376 |
|
2,531 |
1,511 |
$6K |
| 83735 |
|
3,431 |
2,770 |
$6K |
| 87077 |
|
917 |
684 |
$6K |
| 86901 |
|
3,642 |
3,133 |
$6K |
| 83690 |
|
5,836 |
5,093 |
$5K |
| 87186 |
|
3,319 |
2,702 |
$5K |
| 84703 |
|
6,693 |
6,035 |
$5K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
992 |
813 |
$5K |
| 82962 |
|
402 |
357 |
$5K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
127 |
109 |
$5K |
| 74018 |
|
248 |
219 |
$4K |
| 84443 |
Thyroid stimulating hormone (TSH) |
3,455 |
2,971 |
$4K |
| 87081 |
|
3,045 |
2,904 |
$4K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
5,330 |
4,476 |
$3K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
3,118 |
2,598 |
$3K |
| 73080 |
|
85 |
78 |
$3K |
| 87205 |
|
1,047 |
857 |
$3K |
| 85379 |
|
2,278 |
2,047 |
$3K |
| C1769 |
Guide wire |
151 |
109 |
$3K |
| 72131 |
|
99 |
80 |
$2K |
| 82731 |
|
26 |
26 |
$2K |
| J2060 |
Injection, lorazepam, 2 mg |
1,428 |
1,145 |
$2K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,492 |
1,226 |
$2K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,661 |
1,221 |
$2K |
| 76819 |
Fetal biophysical profile; without non-stress testing |
122 |
102 |
$2K |
| 93970 |
|
58 |
49 |
$1K |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
1,115 |
875 |
$1K |
| J3370 |
Injection, vancomycin hcl, 500 mg |
48 |
26 |
$1K |
| 73590 |
|
74 |
62 |
$1K |
| 85014 |
|
86 |
62 |
$1K |
| 82247 |
|
318 |
217 |
$984.69 |
| 87631 |
|
37 |
33 |
$949.83 |
| 73090 |
|
28 |
26 |
$829.30 |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
475 |
363 |
$822.97 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
446 |
416 |
$757.78 |
| 97162 |
|
12 |
12 |
$739.63 |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
8,768 |
8,322 |
$736.36 |
| 86140 |
|
1,059 |
889 |
$727.09 |
| 87581 |
|
8,778 |
8,352 |
$678.17 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
533 |
450 |
$665.19 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
786 |
673 |
$574.54 |
| 97161 |
|
32 |
26 |
$544.92 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
127 |
86 |
$527.50 |
| 85055 |
|
198 |
156 |
$498.14 |
| 85007 |
|
2,360 |
2,200 |
$453.33 |
| 82077 |
|
622 |
545 |
$363.51 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
858 |
705 |
$347.31 |
| 82550 |
|
671 |
547 |
$286.10 |
| J2710 |
Injection, neostigmine methylsulfate, up to 0.5 mg |
148 |
119 |
$281.67 |
| 84439 |
|
341 |
291 |
$276.30 |
| 71250 |
|
42 |
29 |
$270.69 |
| 88142 |
|
107 |
93 |
$262.23 |
| Q0163 |
Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen |
264 |
240 |
$240.00 |
| 74022 |
|
13 |
12 |
$239.89 |
| J2175 |
Injection, meperidine hydrochloride, per 100 mg |
102 |
76 |
$231.20 |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
26 |
12 |
$202.86 |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
56 |
54 |
$194.60 |
| 87045 |
|
14 |
13 |
$175.21 |
| 90715 |
|
130 |
111 |
$171.44 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
309 |
271 |
$168.49 |
| 84481 |
|
98 |
78 |
$155.70 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
3,235 |
3,043 |
$153.06 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
236 |
206 |
$144.68 |
| 86308 |
|
432 |
408 |
$136.73 |
| 85018 |
|
86 |
64 |
$122.05 |
| 82784 |
|
22 |
13 |
$106.08 |
| 85652 |
|
570 |
474 |
$105.17 |
| 80179 |
|
336 |
304 |
$89.47 |
| 82607 |
|
286 |
239 |
$81.59 |
| 82728 |
|
167 |
145 |
$75.83 |
| 76937 |
|
66 |
50 |
$70.49 |
| 29515 |
|
29 |
28 |
$58.60 |
| 84436 |
|
121 |
111 |
$51.82 |
| 82248 |
|
219 |
163 |
$44.98 |
| 85520 |
|
81 |
67 |
$34.40 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
24 |
24 |
$23.88 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
405 |
202 |
$23.00 |
| A9575 |
Injection, gadoterate meglumine, 0.1 ml |
12 |
12 |
$20.61 |
| 84145 |
|
177 |
163 |
$17.24 |
| 87340 |
|
39 |
36 |
$16.65 |
| 83540 |
|
242 |
203 |
$14.42 |
| 84479 |
|
75 |
69 |
$13.65 |
| 83550 |
|
199 |
165 |
$11.59 |
| 82803 |
|
109 |
94 |
$10.11 |
| 84550 |
|
43 |
37 |
$7.78 |
| 82570 |
|
42 |
36 |
$6.26 |
| C9113 |
Injection, pantoprazole sodium, per vial |
531 |
350 |
$5.39 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
564 |
519 |
$4.64 |
| 82746 |
|
64 |
54 |
$3.90 |
| 84156 |
|
46 |
37 |
$3.12 |
| 86803 |
|
14 |
13 |
$0.00 |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
29 |
25 |
$0.00 |
| A9540 |
Technetium tc-99m macroaggregated albumin, diagnostic, per study dose, up to 10 millicuries |
29 |
27 |
$0.00 |
| J2785 |
Injection, regadenoson, 0.1 mg |
55 |
52 |
$0.00 |
| 78580 |
|
32 |
30 |
$0.00 |
| J2360 |
Injection, orphenadrine citrate, up to 60 mg |
66 |
43 |
$0.00 |
| J2920 |
Injection, methylprednisolone sodium succinate, up to 40 mg |
43 |
28 |
$0.00 |
| J1790 |
Injection, droperidol, up to 5 mg |
27 |
26 |
$0.00 |
| 87046 |
|
15 |
13 |
$0.00 |
| 70486 |
|
16 |
14 |
$0.00 |
| 86704 |
|
15 |
13 |
$0.00 |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
13 |
12 |
$0.00 |
| 86706 |
|
16 |
14 |
$0.00 |
| 82553 |
|
13 |
12 |
$0.00 |
| 99156 |
|
22 |
14 |
$0.00 |
| 88342 |
|
22 |
16 |
$0.00 |
| J1940 |
Injection, furosemide, up to 20 mg |
22 |
13 |
$0.00 |
| J7510 |
Prednisolone oral, per 5 mg |
438 |
409 |
$0.00 |
| A9502 |
Technetium tc-99m tetrofosmin, diagnostic, per study dose |
243 |
218 |
$0.00 |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
39 |
27 |
$0.00 |
| J0153 |
Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) |
92 |
84 |
$0.00 |
| 31720 |
|
15 |
12 |
$0.00 |
| 29125 |
|
14 |
13 |
$0.00 |
| 85384 |
|
15 |
13 |
$0.00 |